James Linder Email & Phone

Chief Executive Officer @ Nebraska Medicine

Professor, Pathology and Microbiology @ University of Nebraska Medical Center

Founder @ Tethon 3D

Founder and Managing Director @ Linseed Capital

Board Chair @ Nebraska Applied Research Institute (NARI)

Chief Strategist @ University of Nebraska

President @ University of Nebraska Technology Development Corporation

Interim President @ University of Nebraska

Chief Medical Officer @ Roche Diagnostic Hematology

Chief Medical Officer @ Constituion Medical Investors

Senior Vice President and and or Chief Medical Officer @ Cytyc

1980 - 1982 Residency @ Duke University

1977 - 1980 Doctor of Medicine (M.D.) @ University of Nebraska Medical Center

Medical Diagnostics, Leadership, Laboratory, Clinical Trials, Not for Profit, Molecular Diagnostics, Hardware Diagnostics, Genomics, Infectious Diseases, Angel Investing, Clinical Research, Business Development, Biotechnology, Education, Healthcare, Hematology, Medical Devices, Strategic Planning, Business Planning, Lifesciences, Pathology, Entrepreneurship, Microbiology, Cancer, Business Strategy, Management, Project Management, Research, Technology Transfer, Marketing Strategy, FDA, Commercialization, Hospitals, Sales, Microsoft Office, Strategy

James Linder, based in Omaha, NE, US, is currently a Chief Executive Officer at Nebraska Medicine. James Linder brings experience from previous roles at University of Nebraska Medical Center, Tethon 3D, Linseed Capital, Nebraska Applied Research Institute (NARI), University of Nebraska, University of Nebraska Technology Development Corporation, University of Nebraska, Roche Diagnostic Hematology, Constituion Medical Investors, Cytyc. James Linder holds various educational qualifications including Residency in Pathology (1980 - 1982) from Duke University. With a robust skill set that includes Medical Diagnostics, Leadership, Laboratory, Clinical Trials, Not for Profit, James Linder demonstrates proficiency in a wide range of areas.